NewsRamp Psychedelics Podcast
Explore the emerging world of psychedelics with the 'NewsRamp Psychedelics Podcast.' This podcast delivers the latest news and insights from NewsRamp.com, focusing on research developments, therapeutic applications, and regulatory changes in the psychedelics field. Stay informed on the groundbreaking advancements in this evolving industry.
Episodes
November 13, 2025 • 2 mins
Cybin Inc., a leading neuropsychiatry company, recently announced its successful second-quarter results and highlighted key advancements in its clinical trials and global regulatory approvals. With a focus on revolutionizing mental healthcare, Cybin is actively developing new treatment options for conditions like major depressive disorder and generalized anxiety disorder. George Tziras, the chief business officer, will be presentin...
Mark as Played
November 6, 2025 • 1 min
Cybin Inc., a leading neuropsychiatry company, will be hosting a conference call to discuss Q2 results and provide updates on their innovative treatment options for mental health disorders. Founded in 2019, Cybin is focused on developing solutions for major depressive disorder and generalized anxiety disorder, operating in multiple countries including Canada, the U.S., the U.K., and Ireland. For more details, visit Cybin's newsroom...
Mark as Played
November 5, 2025 • 2 mins
Cybin Inc., a Phase 3 clinical stage neuropsychiatry company, is set to have their Chief Business Officer speak at the Guggenheim 2nd Annual Healthcare Innovation Conference. The company is dedicated to transforming mental healthcare through the development of novel drugs like CYB003 and CYB004 for major depressive disorder and generalized anxiety disorder, respectively, with the goal of providing effective and lasting treatment op...
Mark as Played
November 3, 2025 • 3 mins
Global Psychedelic Week 2025 is the first-ever distributed psychedelic conference, gathering 5,000 participants from 100 countries through a hybrid online and in-person model. With over 100 speakers like Rick Doblin and Robin Carhart-Harris, the event aims to spark global conversations on psychedelic science, therapy, and culture. By hosting in-person gatherings worldwide, GPW fosters a truly global movement from the ground up, pro...
Mark as Played
Cybin Inc., a Phase 3 clinical-stage neuropsychiatry company, will have its Chief Medical Officer, Amir Inamdar, speak at the upcoming 2025 Milken Institute Future of Health Summit in Washington, D.C. The company is dedicated to transforming mental healthcare through innovative treatment options like CYB003 for major depressive disorder and CYB004 for generalized anxiety disorder. Operating in multiple countries since its founding ...
Mark as Played
October 29, 2025 • 2 mins
Cybin Inc. has revealed a registered direct offering of common shares and warrants, raising over $175 million in gross proceeds. The offering includes renowned investors and aims to support the development of innovative treatment options for mental health conditions like major depressive disorder and generalized anxiety disorder.
Mark as Played
October 27, 2025 • 2 mins
Global Psychedelic Week 2025 offers a diverse program with seven themed days, over 100 events, and 140 speakers from around the world. From scientific discovery to indigenous wisdom, the event explores the evolving landscape of psychedelic research. Visionary voices like Robin Carhart-Harris and Rick Doblin will discuss the fusion of ancient wisdom and modern science. With 5,000 participants from 100 countries, the event aims to un...
Mark as Played
October 20, 2025 • 2 mins
Global Psychedelic Week 2025 will feature 130 global speakers and 100 in-person events worldwide, including discussions on psychedelic therapies in crisis zones, evidence-based approaches in psychedelic enterprises, indigenous perspectives, women in psychedelics, and the role of psychedelics in addressing climate change. The conference aims to decentralize the conversation and prioritize inclusivity and community, with early bird r...
Mark as Played
October 17, 2025 • 1 min
NRx Pharmaceuticals is making significant progress in developing preservative-free ketamine-based therapies through two different pathways, including KETAFREE and NRX-100. With FDA approval to remove benzethonium chloride for KETAFREE and Fast Track Designation for NRX-100, the company is demonstrating a commitment to innovative treatments for mental health disorders. CEO Dr. Jonathan Javitt recently highlighted these advancements ...
Mark as Played
NRx Pharmaceuticals Inc. has received FDA approval for a Suitability Petition, allowing them to re-file for their preservative-free ketamine product. This aligns with NRx's focus on developing treatments for suicidal depression and PTSD, while tapping into the growing demand for safer pharmaceutical options in the U.S. market.
Mark as Played
October 2, 2025 • 1 min
Global Psychedelic Week 2025, the first distributed psychedelic conference, will bring together 5,000 people from 100 countries with 100+ speakers like Rick Doblin and Robin Carhart-Harris. With events in nearly 60 cities and partnerships with 70+ organizations, GPW aims to promote global dialogue and action on psychedelics. Early bird registration is now open at www.globalpsychedelicweek.com.
Mark as Played
September 24, 2025 • 2 mins
Cybin Inc. provided updates on its drug discovery platforms, highlighting key milestones such as upcoming Phase 2 and Phase 3 program data releases for anxiety and depression disorders, along with a strategic manufacturing partnership. The Company's intellectual property portfolio is secured until 2041, with promising response rates and FDA Breakthrough Therapy Designation for its CYB003 program.
Mark as Played
September 12, 2025 • 2 mins
Cybin Inc.'s Chief Medical Officer and Chief Business Officer will be participating in a fireside chat at an upcoming summit to discuss the company's focus on developing innovative treatment options for mental health conditions, including their ongoing Phase 3 and Phase 2 studies for major depressive disorder and generalized anxiety disorder, respectively. Established in 2019, Cybin is a clinical-stage neuropsychiatry company with ...
Mark as Played
NRx Pharmaceuticals' subsidiary HOPE Therapeutics Inc. has acquired Dura Medical, a provider of interventional psychiatry services in Florida, expanding its network. Meanwhile, Cybin Inc. has completed enrollment in its Phase 2 study of CYB004 for Generalized Anxiety Disorder, with topline data expected in Q1 2026, aiming to address the needs of millions of Americans living with GAD.
Mark as Played
September 4, 2025 • 1 min
Cybin Inc., a neuropsychiatry company, will have their Chief Business Officer participating in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference to discuss their focus on developing new treatment options for mental health conditions, including CYB003 in Phase 3 studies for major depressive disorder and CYB004 in a Phase 2 study for generalized anxiety disorder. Established in 2019, Cybin is actively op...
Mark as Played
September 3, 2025 • 1 min
Cybin Inc.'s Chief Medical Officer, Amir Inamdar, will be participating in a fireside chat at the Cantor Global Healthcare Conference on September 5, 2025, discussing the company's focus on developing new treatment options for mental health conditions such as major depressive disorder and generalized anxiety disorder. The session will be webcast live and available for replay on Cybin's investor relations website. Founded in 2019, C...
Mark as Played
September 2, 2025 • 2 mins
Cybin Inc. appoints Eric So as Interim CEO following Doug Drysdale's resignation, focusing on advancing clinical pipeline for mental health conditions. Meanwhile, NRx Pharmaceuticals Inc. secures FDA Fast Track designation for IV ketamine formulation NRX-100 in treating suicidal depression, expanding its potential patient pool.
Mark as Played
August 28, 2025 • 2 mins
Psylutions, a pioneering cultivator and manufacturer of psilocybin in Colorado, praises the DEA's decision to advance a petition to reschedule psilocybin for scientific review by the U.S. Department of Health and Human Services. This move is seen as a significant stride towards mainstream acceptance of psychedelics in medicine, offering hope for patients in palliative care and Veterans with PTSD. Psylutions is poised to lead the ch...
Mark as Played
August 27, 2025 • 2 mins
Ketamine Lead Gen partners with HealingMaps and Healing Health Alliance to support the growth of Ketamine & TMS clinics by providing patient education, digital marketing, and operational solutions. The collaboration aims to enhance clinic profitability and scalability through high-intent patient discovery, measurable marketing strategies, and exclusive benefits for clinic owners.
Mark as Played
August 27, 2025 • 2 mins
Cybin Inc. has been granted approval to start the EMBRACE Phase 3 study of CYB003 in Australia, marking a significant milestone in their development of new treatment options for mental health conditions. This study is part of Cybin's Phase 3 multinational program, PARADIGM, and focuses on major depressive disorder.
Mark as Played
Popular Podcasts
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!